Recently 3 very intelligent doctor friends of mine sent me the following article:
My response to the 3 was:
"I feel like I am living in the movie "groundhog day!"
WHY?
This has been known since 1996, and yet no one is doing anything about this clinically (except just me?)
It is important to realize that clinical research and clinical delivery are 2 separate industries. If the CEO of some drug company or a guy like Fauci with too much power does not want the technology in the hands of clinicians, it will not get there - period.
Dr. Tanzi et al. - Chaired professor of Neurology at Harvard Medical School, published a paper in 2003 (20 years ago) that clearly demonstrated the link between cortical cataracts and Alzheimer's.
A supranuclear cataract is a fancy term for a cortical cataract.
What did they do? They started a company to build an instrument to detect and quantify the supranuclear cataract. But this fancy device was/is not needed. A Simple slit lamp microscope in EVERY optometry and ophthalmology office detects and measures the supranuclear cataract.
My question is, with this knowledge, why didn't Harvard - through Mass General, Brigham and Women's, and Beth Israel hospitals screen everyone for supranuclear (cortical) cataracts?
The initial company was called Neuroptix. For some reason this company failed but they forged on and formed a new company called Cognipix.
Have you heard of them? Have you been screened for Alzheimer's?
Imagine if Harvard hospitals started screening older people for Alzheimer's starting in 2003. It is a 20-minute test and costs almost nothing to perform. I estimate 5 million people could have been screened over the last 20 years just at the Harvard hospitals.
There are 38,000 optometrists in the U.S. With this army of diagnosticians; the entire U.S. population could have been screened by now - a couple of times over.
Here is the program I offer - since Harvard will not - without substantial financial gain.
We provide this sheet that you take to your optometrist to obtain the proper tests then I interpret the results wrt Alzheimer's risk.
Your eye is an outcropping of the brain. This is a book by another Harvard professor:
Alzheimer's shows up in the eye in at least 3 main places:
The retina: the retinal nerve fiber layer - measured with the OCT instrument.
The optic nerve area - measured with a fundus camera
The lens - measured with a slit lamp microscope.
The recent Fox News report states, as quoted from the experts...
"Results could lead to earlier testing.
This study is the most comprehensive analysis of the human retina in terms of how it relates to the brains and cognitive functions of Alzheimer’s patients."
The article does NOT reference any previous work. The actual paper does cite the 1996 work.
Please note that they refer to the "Alzheimer's plaque" (in the research article) as "synaptotoxic AβO." This has long been proven false by a deceased colleague at Harvard - Robert Moir.
However, the drug industry will "soldier on" a develop a drug against the wrong target.
What causes these "deadly" formations? Here is what Dr. Moir published in 2010 and 2016.
And - the ultimate interview on this topic with Dr. Moir.
Translation: The target of the drug industrial complex is substances that are part of our PROTECTIVE INNATE IMMUNE RESPONSE! UGH
God help us!
Besides the eye tests, what other tests should you obtain:
white blood cell counts
neutrophil to lymphocyte ratio
high sensitivity c reactive protein
fibrinogen activity
root canals and oral pathogens/spirochetes with the OralDNA test
Lyme line blot
chlamydia pneumoniae
h pylori
rickettsial disease pathogens (several types)
Q fever
Toxoplasma gondii
Various viruses https://pubmed.ncbi.nlm.nih.gov/34205498/
If you want to know more about the eye/brain connection, I have written an entire chapter on this subject in my book "Health Freedom Lost," chapter 2. Write to Jodi at jlaird@healthrevivalpartners.com, and she will send you a link to that book for a donation of $20.
The webinars this week are:
Monday the 20th of March: Arden Ballard- BioProtein arden@bioproteintech.com Topic: “Discover the Non-Invasive Approach to Healing Growth Factors” Bio: Arden Ballard, MS, PA-C, ATC Arden Ballard is a Physician Assistant, Athletic Trainer, and Clinical Wholesale Director for BioProtein Technology.
Wednesday the 22nd of March: Same speaker.
Weekly Webinar Links: Join us for detailed health information - at no charge. All are welcome.
Monday at noon EST -
https://zoom.us/j/94642492535?pwd=c2IyOTRoQTdNQ3JhTFdlVXpPMGErUT09
Wednesday at 8 pm EST -
https://zoom.us/j/96863715606?pwd=VTRCNTQ1dEVoWnlRQjRkeGJYRXlSdz09
Be Bold - Be Brave - Stay Well
Comentarios